Pernix Therapeutics, Somaxon deal

Specialty pharma Pernix will acquire Somaxon in stock deal that values Somaxon at $25 million. Somaxon shareholders will receive a number of Pernix shares based on the price of Pernix's shares over the 30 days prior to the closing of the deal, which is expected next quarter. The price of the deal is expected to be $6-$9 per share. The deal has been approved by the boards of both companies. Stifel Nicolaus Weisel is advising Somaxon. ...